Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-27

Study Completion Date

2020-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to evaluate whether rapid first contact with the oncologist the same day or the next day after pathologic diagnosis contributes to a decreased time to treatment, decreased patient anxiety and increased patient satisfaction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Detection of Cancers in Low Resource Countries

NCT01178736

Breast Neoplasms Uterine Cervical Neoplasms Ovarian Neoplasms +1 more

UNKNOWN

Ultrasound and Photoacoustic Imaging for Cervical Cancer

NCT03318107

Cervical Cancer Cancer of the Cervix

TERMINATED NA

Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit

NCT00237562

Cervical Intraepithelial Neoplasia

COMPLETED PHASE3

Improving Sexual Health in Gynecologic Cancer Patients

NCT03827993

Gynecologic Cancer

TERMINATED NA

Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

NCT01164735

Recurrent Uterine Corpus Carcinoma Stage III Uterine Corpus Cancer Stage IV Uterine Corpus Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Time to treatment (time from disease diagnosis to initiation of treatment) impacts outcomes in uterine cancer. When controlled for stage, patients with longer time to treatment tend to have less favorable outcomes. Similarly, longer time to treatment has a negative impact on patients' quality of life and markers for anxiety. Our experience at this institution suggests that the time to referral (time from uterine cancer diagnosis and the patients' first encounter with the oncologist) is variable and presents the greatest opportunity for decreasing time to treatment. Among the factors that contribute to the time to referral are the time taken by the referring provider to relay the diagnosis to the patient, time taken to schedule an appointment with the specialist, and the patient's availability to keep an appointment.

Virtual visits provide an opportunity to expedite consultation with the treating oncologist by removing some of the barriers that delay face-to-face visits. Among these barriers are patients' availability for a short notice face-to-face visit based on their work or family obligations, access to transportation, and mental preparedness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Uterine Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rapid first contact virtual visit

Subjects will accept the offer of a virtual visit after being contacted by the nurse to offer a virtual visit with the oncologist prior to the in person office visit once a diagnosis has been confirmed. Subjects will be randomized after accepting offer of a virtual visit.

Group Type ACTIVE_COMPARATOR

Virtual visit

Intervention Type BEHAVIORAL

Virtual visit with oncologist following uterine cancer diagnosis prior to scheduled office visit.

First contact in person office visit

Subjects will accept the offer of a virtual visit after being contacted by the nurse to offer a virtual visit with the oncologist prior to the in person office visit once a diagnosis has been confirmed. Subjects will be randomized after accepting offer of a virtual visit.

Group Type PLACEBO_COMPARATOR

Office visit

Intervention Type BEHAVIORAL

Scheduled office visit with oncologist following uterine cancer diagnosis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual visit

Virtual visit with oncologist following uterine cancer diagnosis prior to scheduled office visit.

Intervention Type BEHAVIORAL

Office visit

Scheduled office visit with oncologist following uterine cancer diagnosis.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Uterine cancer diagnosis on biopsy read by Cleveland Clinic Pathology Department
* Patients must be willing to participate in a virtual visit as the initial meeting with an oncologist at the Cleveland Clinic.
* Receive care at Fairview Hospital, Hillcrest Hospital or Cleveland Clinic Main Campus
* Internet connected smartphone or internet connected computer with webcam
* Participants must have email access
* English speaking
* Competent to make clinic decisions